Catalyst Pharmaceuticals, Inc.CPRXNASDAQ
LOADING
|||
Switch Symbol:
Operating Income Scaling
Trending higher, above historical average.
Left:
||||
Profit from core business operations before interest and taxes
Latest
$195.12M
↑ 369% above average
Average (9y)
$41.56M
Historical baseline
Range
High:$195.12M
Low:$-35.30M
CAGR
NaN%
Modest growth trend
| Period | Value | Change |
|---|---|---|
| 2024 | $195.12M | +124.8% |
| 2023 | $86.81M | -14.8% |
| 2022 | $101.84M | +94.4% |
| 2021 | $52.38M | +26.8% |
| 2020 | $41.30M | +29.8% |
| 2019 | $31.82M | +190.2% |
| 2018 | $-35.30M | -88.9% |
| 2017 | $-18.68M | +3.1% |
| 2016 | $-19.28M | +5.5% |
| 2015 | $-20.40M | - |